Dr. Robert Pollock, MD

NPI: 1538148572
Total Payments
$245,434
2024 Payments
$34,888
Companies
5
Transactions
162

Payment Breakdown by Category

Consulting$243,623 (99.3%)
Travel$1,753 (0.7%)
Food & Beverage$56.88 (0.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $243,623 137 99.3%
Travel and Lodging $1,753 21 0.7%
Food and Beverage $56.88 4 0.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $177,663 122 $0 (2024)
Shire North American Group Inc $67,713 36 $0 (2019)
Vanda Pharmaceuticals Inc. $24.01 2 $0 (2017)
PFIZER INC. $17.60 1 $0 (2018)
RARE DISEASE THERAPEUTICS, INC. $15.27 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $34,888 34 Takeda Pharmaceuticals U.S.A., Inc. ($34,888)
2023 $16,853 8 Takeda Pharmaceuticals U.S.A., Inc. ($16,853)
2022 $27,893 14 Takeda Pharmaceuticals U.S.A., Inc. ($27,893)
2021 $49,581 32 Takeda Pharmaceuticals U.S.A., Inc. ($49,581)
2020 $48,448 34 Takeda Pharmaceuticals U.S.A., Inc. ($48,448)
2019 $41,962 23 Shire North American Group Inc ($41,947)
2018 $20,991 11 Shire North American Group Inc ($20,973)
2017 $4,818 6 Shire North American Group Inc ($4,794)

All Payment Transactions

162 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,103.34 General
12/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $72.36 General
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,106.67 General
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,053.34 General
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $190.28 General
11/20/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $526.67 General
11/20/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $95.14 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,106.67 General
11/04/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $526.67 General
11/04/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $95.14 General
10/21/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $526.67 General
10/21/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $95.14 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,106.67 General
10/02/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $526.67 General
10/02/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $526.67 General
10/02/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $95.14 General
10/02/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $95.14 General
09/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $526.67 General
09/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $95.14 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,106.67 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $526.67 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $526.67 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $95.14 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $95.14 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,106.67 General

About Dr. Robert Pollock, MD

Dr. Robert Pollock, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538148572.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Pollock, MD has received a total of $245,434 in payments from pharmaceutical and medical device companies, with $34,888 received in 2024. These payments were reported across 162 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($243,623).

Practice Information

  • Specialty Anatomic Pathology & Clinical Pathology
  • Other Specialties Clinical Pathology
  • Location Orlando, FL
  • Active Since 01/10/2006
  • Last Updated 10/22/2007
  • Taxonomy Code 207ZP0102X
  • Entity Type Individual
  • NPI Number 1538148572

Products in Payments

  • Fanapt (Drug) $24.01
  • CHANTIX (Drug) $17.60
  • Anavip (Biological) $15.27

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in Orlando